Find a Location
Seattle Children's Hospital
Led by Catherine Pihoker, MD, the TrialNet team at Seattle Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, Seattle Children's Hospital is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution.
St. Lukes Humphreys Diabetes Center
Led by Daniel Flynn, MD, the TrialNet team at St. Lukes Humphreys Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, St. Lukes Humphreys Diabetes Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution.
Stanford University
Stanford University is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Texas Tech University - Amarillo
Led by Maria Contreras, MD, the TrialNet team at Texas Tech University Health Sciences Center at Amarillo is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, Texas Tech University Health Sciences Center is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution.
The Hospital for Sick Children
The Hospital for Sick Children (SickKids) is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
The University of Oklahoma
Led by David Sparling, MD, PhD, the TrialNet team at University of Oklahoma Health Sciences Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, University of Oklahoma Health Sciences Center is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution.
TMH Physician Partners Endocrine, Diabetes and Obesity Center
Led by Dr. Larry Deeb, the TrialNet team at the TMH Physician Partners Endocrine, Diabetes and Obesity Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, TTMH Physician Partners Endocrine, Diabetes and Obesity Center is regionally overseen by the University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution.
Touro University
Led by Dr. Jay Shubrook, DO, the TrialNet team at Touro University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, Touro University is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution.
University of Arizona Pediatric Endocrinology
Led by Cindy Chin, MD, the TrialNet team at University of Arizona Pediatric Endocrinology is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, University of Arizona Pediatric Endocrinology is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution.
University of British Columbia
Led by Constadina Panagiotopoulos, MD, the TrialNet team at University of British Columbia is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, University of British Columbia is regionally overseen by The Hospital for Sick Children. If you reach out to TrialNet, you may be contacted by staff from either institution.